Microsatellite (GT)(n) is part of the von Willebrand factor (VWF) promoter region that influences the glucocorticoid-induced increase in VWF in Cushing's syndrome.
BACKGROUND
The cortisol-induced increase in von Willebrand factor (VWF) in Cushing's syndrome (CS) seems to depend on single nucleotide polymorphisms (SNPs) of the VWF promoter, haplotype 1 (-3268G/-2709C/-2661A/-2527G) being the susceptible pattern.


METHODS
This study focused on a new variable region of the VWF promoter, the -2144(GT)(n) locus, to establish whether different GT-repeat lengths are also involved in modulating the cortisol-induced increase in VWF. Sixty-nine CS patients were investigated, divided into groups A (high VWF) and B (normal VWF).


RESULTS
Analysing the (GT)(n) locus revealed a similar allele distribution in CS patients and normal subjects, (GT)(n) variants ranging from 15 to 24 repeats and (GT)(19) and (GT)(21) being the two most represented. However, when groups A and B were analysed separately, a different allele distribution was observed: short GT-repeats (15-19, GT(S)) were more frequent in group A, long GT-repeats (20-24, GT(L)) in group B (p=0.01). About genotype distributions, (GT)(S)/(GT)(S) was higher in group A and rare in group B (22.5% and 3.4%, respectively), whereas (GT)(L)/(GT)(L) was higher in group B than in group A (55.2%, 27.5%) (p=0.021). Odds-ratio analysis revealed a risk of a cortisol-dependent increase in VWF three times higher for alleles (GT)(S) than for (GT)(L), and 13-fold for genotype (GT)(S)/(GT)(S) respect to (GT)(L)/(GT)(L).


CONCLUSIONS
In conclusion, not only the SNPs haplotypes in the VWF gene promoter, but also the variable-length (GT)(n) locus predict the risk of developing high VWF levels under conditions of glucocorticoid excess; the combination of (GT)(S) and haplotype 1 represents the susceptible pattern.
Department of Cardiological, Thoracic and Vascular Sciences, Second Chair of Internal Medicine, University of Padua Medical School, Padua, Italy.
Viviana
V
Daidone
Elena
E
Pontara
Chiara
C
Romualdi
Maria G
MG
Cattini
Carla
C
Scaroni
Nora
N
Albiger
Antonio
A
Pagnan
Alessandra
A
Casonato
D000328:Adult; D016022:Case-Control Studies; D003480:Cushing Syndrome / Q000175:diagnosis / Q000235:genetics* / Q000378:metabolism; D005260:Female; D020022:Genetic Predisposition to Disease; D005938:Glucocorticoids / Q000494:pharmacology*; D006239:Haplotypes; D006801:Humans; D008297:Male; D018895:Microsatellite Repeats; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D014841:von Willebrand Factor / Q000187:drug effects / Q000235:genetics*
D005938:Glucocorticoids; D014841:von Willebrand Factor